230 related articles for article (PubMed ID: 33066107)
1. Effects of
Amat-Bou M; Garcia-Ribera S; Climent E; Piquer-Garcia I; Corripio R; Sanchez-Infantes D; Villalta L; Elias M; Jiménez-Chillarón JC; Chenoll E; Ramón D; Ibañez L; Ramon-Krauel M; Lerin C
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33066107
[TBL] [Abstract][Full Text] [Related]
2. The effects of Bifidobacterium animalis ssp. lactis B94 on gastrointestinal wellness in adults with Prader-Willi syndrome: study protocol for a randomized controlled trial.
Alyousif Z; Miller JL; Sandoval MY; MacPherson CW; Nagulesapillai V; Dahl WJ
Trials; 2018 Apr; 19(1):256. PubMed ID: 29703235
[TBL] [Abstract][Full Text] [Related]
3. Altered Salivary Microbiota Following Bifidobacterium animalis Subsp. Lactis BL-11 Supplementation Are Associated with Anthropometric Growth and Social Behavior Severity in Individuals with Prader-Willi Syndrome.
Liu K; Kong XJ
Probiotics Antimicrob Proteins; 2022 Aug; 14(4):699-711. PubMed ID: 35474569
[TBL] [Abstract][Full Text] [Related]
4. The Effects of Probiotic Supplementation on Anthropometric Growth and Gut Microbiota Composition in Patients With Prader-Willi Syndrome: A Randomized Double-Blinded Placebo-Controlled Trial.
Kong XJ; Wan G; Tian R; Liu S; Liu K; Clairmont C; Lin X; Zhang X; Sherman H; Zhu J; Wang Y; Fong M; Li A; Wang BK; Wang J; Liu J; Yu Z; Shen C; Cui X; Cao H; Du T; Cao X
Front Nutr; 2021; 8():587974. PubMed ID: 33681271
[No Abstract] [Full Text] [Related]
5. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
Whitman BY; Myers S; Carrel A; Allen D
Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
[TBL] [Abstract][Full Text] [Related]
6. Lipoteichoic acid from Bifidobacterium animalis subsp. lactis BPL1: a novel postbiotic that reduces fat deposition via IGF-1 pathway.
Balaguer F; Enrique M; Llopis S; Barrena M; Navarro V; Álvarez B; Chenoll E; Ramón D; Tortajada M; Martorell P
Microb Biotechnol; 2022 Mar; 15(3):805-816. PubMed ID: 33620143
[TBL] [Abstract][Full Text] [Related]
7. Microbiota profile and efficacy of probiotic supplementation on laxation in adults affected by Prader-Willi Syndrome: A randomized, double-blind, crossover trial.
Alyousif Z; Miller JL; Auger J; Sandoval M; Piano A; Tompkins TA; Dahl WJ
Mol Genet Genomic Med; 2020 Dec; 8(12):e1535. PubMed ID: 33103385
[TBL] [Abstract][Full Text] [Related]
8. The Effects of Limosilactobacillus reuteri LR-99 Supplementation on Body Mass Index, Social Communication, Fine Motor Function, and Gut Microbiome Composition in Individuals with Prader-Willi Syndrome: a Randomized Double-Blinded Placebo-Controlled Trial.
Kong XJ; Liu K; Zhuang P; Tian R; Liu S; Clairmont C; Lin X; Sherman H; Zhu J; Wang Y; Fong M; Li A; Wang BK; Wang J; Yu Z; Shen C; Cui X; Cao H; Du T; Wan G; Cao X
Probiotics Antimicrob Proteins; 2021 Dec; 13(6):1508-1520. PubMed ID: 34115318
[TBL] [Abstract][Full Text] [Related]
9. Effect of Genotype and Previous GH Treatment on Adiposity in Adults With Prader-Willi Syndrome.
Coupaye M; Tauber M; Cuisset L; Laurier V; Bieth E; Lacorte JM; Oppert JM; Clément K; Poitou C
J Clin Endocrinol Metab; 2016 Dec; 101(12):4895-4903. PubMed ID: 27662437
[TBL] [Abstract][Full Text] [Related]
10. Behavioral changes in patients with Prader-Willi syndrome receiving diazoxide choline extended-release tablets compared to the PATH for PWS natural history study.
Strong TV; Miller JL; McCandless SE; Gevers E; Yanovski JA; Matesevac L; Bohonowych J; Ballal S; Yen K; Hirano P; Cowen NM; Bhatnagar A
J Neurodev Disord; 2024 Apr; 16(1):22. PubMed ID: 38671361
[TBL] [Abstract][Full Text] [Related]
11. Specific Dietary Components and Gut Microbiota Composition are Associated with Obesity in Children and Adolescents with Prader-Willi Syndrome.
Garcia-Ribera S; Amat-Bou M; Climent E; Llobet M; Chenoll E; Corripio R; Ibáñez L; Ramon-Krauel M; Lerin C
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32290434
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant Probiotics of
Wang CH; Yen HR; Lu WL; Ho HH; Lin WY; Kuo YW; Huang YY; Tsai SY; Lin HC
Front Endocrinol (Lausanne); 2022; 13():754401. PubMed ID: 35299968
[TBL] [Abstract][Full Text] [Related]
13. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome.
Goldstone AP; Holland AJ; Butler JV; Whittington JE
Int J Obes (Lond); 2012 Dec; 36(12):1564-70. PubMed ID: 22270375
[TBL] [Abstract][Full Text] [Related]
14. A randomized pilot efficacy and safety trial of diazoxide choline controlled-release in patients with Prader-Willi syndrome.
Kimonis V; Surampalli A; Wencel M; Gold JA; Cowen NM
PLoS One; 2019; 14(9):e0221615. PubMed ID: 31545799
[TBL] [Abstract][Full Text] [Related]
15. Matrix Effects on the Delivery Efficacy of Bifidobacterium animalis subsp.
Ba Z; Lee Y; Meng H; Kris-Etherton PM; Rogers CJ; Lewis ZT; Mills DA; Furumoto EJ; Rolon ML; Fleming JA; Roberts RF
mSphere; 2021 Aug; 6(4):e0008421. PubMed ID: 34232082
[TBL] [Abstract][Full Text] [Related]
16. Oxytocin in young children with Prader-Willi syndrome: Results of a randomized, double-blind, placebo-controlled, crossover trial investigating 3 months of oxytocin.
Damen L; Grootjen LN; Juriaans AF; Donze SH; Huisman TM; Visser JA; Delhanty PJD; Hokken-Koelega ACS
Clin Endocrinol (Oxf); 2021 May; 94(5):774-785. PubMed ID: 33296519
[TBL] [Abstract][Full Text] [Related]
17. Prader-Willi syndrome is associated with activation of the innate immune system independently of central adiposity and insulin resistance.
Viardot A; Sze L; Purtell L; Sainsbury A; Loughnan G; Smith E; Herzog H; Steinbeck K; Campbell LV
J Clin Endocrinol Metab; 2010 Jul; 95(7):3392-9. PubMed ID: 20444923
[TBL] [Abstract][Full Text] [Related]
18. Postprandial metabolism in adults with Prader-Willi syndrome.
Purtell L; Viardot A; Sze L; Loughnan G; Steinbeck K; Sainsbury A; Herzog H; Smith A; Campbell LV
Obesity (Silver Spring); 2015 Jun; 23(6):1159-65. PubMed ID: 25958986
[TBL] [Abstract][Full Text] [Related]
19. In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels.
Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
Neuropeptides; 2011 Aug; 45(4):301-7. PubMed ID: 21722955
[TBL] [Abstract][Full Text] [Related]
20. In vitro Cholesterol Assimilation by Bifidobacterium animalis subsp. lactis (BPL1) Probiotic Bacteria Under Intestinal Conditions.
Fernández-Calderón MC; Sánchez-Moro MDH; Rincón EO
Endocr Metab Immune Disord Drug Targets; 2022; 22(4):433-439. PubMed ID: 34496737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
